Prof. Dr. Anette-Gabriele Ziegler, med.

Anette-Gabriele Ziegler studied medicine in Munich, Germany. After working as a physician in Munich, Klinikum Schwabing, she received postdoctoral training at the Joslin Diabetes Center and the Harvard Medical School. In 1989 she returned to the Klinikum Schwabing Munich, and started her independent laboratory at the Forschergruppe Diabetes e. V.

In 1993 she was awarded the Heisenberg Career Development Award of the Deutsche Forschungsgemeinschaft, the central and most important research funding organization in Germany. She received her specialization in Internal Medicine (1991) and Endocrinology (1994), and became Adjunct Professor at the Ludwig-Maximilians-University in Munich (1998).  

From 2007 to 2009 she was Director of the Department of Endocrinology at the Klinikum Schwabing in Munich. Her clinical research achievements led to her recruitment at Helmholtz Munich and the Technische Universität München (TUM) as Chair (full professor W3) to establish the Institute of Diabetes Research in 2010, the starting point for what is now a comprehensive and internationally recognized diabetes research department at Helmholtz Munich.  Jointly with Helmholtz Munich and TUM she has built one of the most renowned Study Centers for Childhood Diabetes - Early Care and Prevention.

She has held several prominent roles, including Speaker of the German Competence Network Diabetes Mellitus and one of the type 1 diabetes academy heads of the German Center for Diabetes Research DZD e.V.
She initiated the Global Platform for the Prevention of Autoimmune Diabetes (GPPAD), where she serves as Speaker, and is one of seven international principal investigators of the NIH funded TEDDY (The Environmental Determinant of Diabetes in the Young) Consortium. Additionally, she represent Germany in the NIH funded TrialNet consortium, and co-lead the newly awarded European HORIZON-IHI program EDENT1FI (European action for the Diagnosis of Early Non-symptomatic Type 1 diabetes For Intervention).

She has organized the German Diabetes Congress as well as the Immunology and Diabetes Society Congress and has successfully established a distinguished annual Symposium on type 1 diabetes in Germany that attracts the world’s leading scientists. Her contributions to the field has been recognized with numerous research prizes including the prestigious Mary Taylor Moore Excellence Award of the Juvenile Diabetes Research Foundation, the EASD-Novo Nordisk Foundation Diabetes Prize for Excellence, and the Paul Langerhans Medal, the highest honor awarded by the German Diabetes Association.

Throughout her career, she has trained numerous clinician scientists who have gone on to win significant awards for their work in type 1 diabetes. Since 2022 she has been a member of the Bavarian Academy of Sciences and Humanities.